High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer
NCT00415233
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
438
Enrollment
OTHER
Sponsor class
Conditions
Head and Neck Cancer
Interventions
BIOLOGICAL:
recombinant thyroid-stimulating hormone
RADIATION:
Radiodine ablation without rhTSH
Sponsor
University College, London